Tablets a 'disruptive technology' for radiologists; New biochip could enable portable flu strain detection;

> Quality evidence-based guidelines, strong leadership and accountability are necessary for clinical decision support with computerized physician order-entry to work for diagnostic imaging, Brigham and Women's Hospital radiologist Ramin Khorasani said Sunday during a presentation at the annual Society for Imaging and Informatics in Medicine (SIIM) meeting in Orlando, Fla., reported. "CDS will only be accepted if based on credible, evidence-based guidelines," he said. "Evidence cannot be unambiguous. It must be actionable and embedded in workflow for immediate access." Article (registration required)

> Also speaking at SIIM, Johns Hopkins radiologist Carl Miller called tablets "a disruptive technology" in his field, CMIO reported. Miller said that imaging professionals could become "more embedded in the clinical care setting" through enhanced consultations and clinician education efforts. Article

> A new biochip designed by researchers at Brown University could be used to track new disease outbreaks, as well as to detect drug-resistant strains of HIV and tuberculosis, according to an article published this morning in Technology Review. Currently, the researchers have developed a method for amplifying RNA on a chip without having to resort to temperature change. Article

And Finally… Didn't Homer Simpson already try this? Article

Suggested Articles

Healthcare’s RCM processes are in dire need of a 21st-century update that delivers greater automation and real-time transparency.

Amazon's PillPack and Surescripts, owned by CVS Health and Express Scripts, are in a dispute over access to patient medication history data.

Healthcare software company Phreesia closed its first day of trading as a public company Thursday about 40% above its set price.